Quell Therapeutics Advances QEL-001, Its Multi-Modular Engineered CAR-Treg Cell Therapy, Into Efficacy Cohort Of LIBERATE Phase 1/2 Trial In Liver Tra...
Progress in the LIBERATE trial was presented at the American Transplant
Source: menafn.com
Liver Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Liver Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Liver Studies Today - Breaking & Trending Today
FDA Approves Second Gene Therapy for Hemophilia B
Pfizer reported a list price of $3.5 million for its new gene therapy, Beqvez, for adults with this rare bleeding disorder.
Source: medscape.com
Early Olezarsen Results Show 50% Reduction in Triglycerides
A drug targeting mRNA essential for APO C-III production provided a 50% reduction in triglycerides in BRIDGE-TIMI 73a, the largest ever observed in a controlled trial.
Source: medscape.com
Seladelpar Could 'Raise the Bar' in PBC Treatment
The investigational agent significantly improved liver biomarkers of disease activity and symptoms of pruritus in adults with PBC enrolled in a phase 3 trial.
Source: medscape.com
Undiagnosed Cirrhosis May Underlie Some Dementia Cases
Some US veterans diagnosed with dementia may have undiagnosed advanced fibrosis or cirrhosis that could explain their cognitive impairment.
Source: medscape.com